Abstract

Antioxidant substances of plant origin, such as lycopene, may favorably affect the skeletal system. Lycopene is a carotenoid pigment, responsible for characteristic red color of tomatoes. It is believed that lycopene may play a role in the prevention of various diseases; despite theoretical premises and results of experimental studies, the effectiveness of lycopene has not yet been clearly demonstrated in studies carried out in humans. The aim of the study was to present the current state of knowledge on the effects of lycopene on the osseous tissue in in vitro and in vivo experimental models and on the skeletal system in humans.Results of the studies indicate that lycopene may inhibit bone resorption. Favorable effects of high doses of lycopene on the rat skeletal system in experimental conditions, including the model of osteoporosis induced by estrogen deficiency, have been demonstrated. The few epidemiological and clinical studies, although not fully conclusive, suggest a possible beneficial effect of lycopene present in the diet on the skeletal system.

References

• 1. Almeida M.: Aging mechanisms in bone. Bonekey Rep., 2012;1: 102
  Google Scholar
• 2. Bayramoglu A., Bayramoglu G., Senturk H.: Lycopene partiallyreverses symptoms of diabetes in rats with streptozotocin-induceddiabetes. J. Med. Food, 2013; 16: 128-132
  Google Scholar
• 3. Belter A., Giel-Pietraszuk M., Oziewicz S., Chomczyński P., BarciszewskiJ.: Likopen -występowanie, właściwości oraz potencjalnezastosowanie. Postępy Biochem., 2011; 57: 372-380
  Google Scholar
• 4. Blanquet-Diot S., Soufi M., Rambeau M., Rock E., Alric M.: Digestivestability of xanthophylls exceeds that of carotenes as studied ina dynamic in vitro gastrointestinal system. J. Nutr., 2009; 139: 876-883
  Google Scholar
• 5. Böhm V.: Lycopene and heart health. Mol. Nutr. Food Res., 2012;56: 296-303
  Google Scholar
• 6. Böhm V., Puspitasari-Nienaber N.L., Ferruzzi M.G., Schwartz S.J.:Trolox quivalent antioxidant capacity of different geometrical isomersof α-carotene, β-carotene, lycopene, and zeaxanthin. J. Agric.Food Chem., 2002; 50: 221-226
  Google Scholar
• 7. Boileau T.W., Boileau A.C., Erdman J.W.Jr.: Bioavailability of alltransand cis-isomers of lycopene. Exp. Biol. Med., 2002; 227: 914-919
  Google Scholar
• 8. Bronkowska M., Biernat J.: Ocena spożycia likopenu w całodziennychracjach pokarmowych kobiet z Dolnego Śląska. Rocz. Państw.Zakł. Hig., 2009; 60: 31-34
  Google Scholar
• 9. Canalis E., Mazziotti G., Giustina A., Bilezikian J.P.: Glucocorticoid-inducedosteoporosis: pathophysiology and therapy. Osteoporos.Int., 2007; 18: 1319-1328
  Google Scholar
• 10. Chen J., Song Y., Zhang L.: Lycopene/tomato consumption andthe risk of prostate cancer: a systematic review and meta-analysisof prospective studies. J. Nutr. Sci. Vitaminol., 2013; 59: 213-223
  Google Scholar
• 11. Elefteriou F.: Regulation of bone remodeling by the central and peripheralnervous system. Arch. Biochem. Biophys., 2008; 473: 231-236
  Google Scholar
• 12. Ford N.A., Erdman J.W.Jr.: Are lycopene metabolites metabolicallyactive? Acta Biochim. Pol., 2012; 59: 1-4
  Google Scholar
• 13. Giovannetti M., Avio L., Barale R., Ceccarelli N., Cristofani R.,Iezzi A., Mignolli F., Picciarelli P., Pinto B., Reali D., Sbrana C., ScarpatoR.: Nutraceutical value and safety of tomato fruits producedby mycorrhizal plants. Br. J. Nutr., 2012; 107: 242-251
  Google Scholar
• 14. Gryszczyńska A., Gryszczyńska B., Opala B.: Karotenoidy. Naturalneźródła, biosynteza, wpływ na organizm ludzki. Post. Fitoter.,2011; 2: 127-143
  Google Scholar
• 15. Hamułka J., Wawrzyniak A., Sulich A.: Ocena spożycia β-karotenu,likopenu i luteiny w wybranej grupie osób dorosłych. Rocz. Państw.Zakł. Hig., 2012; 63: 179-185
  Google Scholar
• 16. Hirsch K., Atzmon A., Danilenko M., Levy J., Sharoni Y.: Lycopeneand other carotenoids inhibit estrogenic activity of 17β-estradiol andgenistein in cancer cells. Breast Cancer Res. Treat., 2007; 104: 221-230
  Google Scholar
• 17. Holzapfel N.P., Holzapfel B.M., Champ S., Feldthusen J., ClementsJ., Hutmacher D.W.: The potential role of lycopene for the preventionand therapy of prostate cancer: from molecular mechanisms toclinical evidence. Int. J. Mol. Sci., 2013; 14: 14620-14646
  Google Scholar
• 18. Iimura Y., Agata U., Takeda S., Kobayashi Y., Yoshida S., Ezawa I.,Omi N.: Lycopene intake facilitates the increase of bone mineral densityin growing female rats. J. Nutr. Sci. Vitaminol., 2014; 60: 101-107
  Google Scholar
• 19. Ilic D., Forbes K.M., Hassed C.: Lycopene for the prevention ofprostate cancer. Cochrane Database Syst. Rev., 2011; 11: CD008007
  Google Scholar
• 20. Ishimi Y., Ohmura M., Wang X., Yamaguchi M., Ikegami S.: Inhibitionby carotenoids and retinoic acid of osteoclast-like cell formationinduced by bone-resorbing agents in vitro. J. Clin. Biochem.Nutr., 1999; 27: 113-122
  Google Scholar
• 21. Janiec W., Folwarczna J., Kaczmarczyk-Sedlak I.: Leki wpływającena układ kostny. W: Kompedium farmakologii, red.: Janiec W.,Wydawnictwo Lekarskie PZWL, Warszawa 2010, 385-399
  Google Scholar
• 22. Kakutani Y., Aikawa Y., Ezawa I., Omi N.: The effects of lycopeneintake and exercise on bone health in young female rats. J. Int. Soc.Sports Nutr., 2011; 8 (Suppl. 1): P30
  Google Scholar
• 23. Kim L., Rao A.V., Rao L.G.: Lycopene II – effect on osteoblasts:the carotenoid lycopene stimulates cell proliferation and alkalinephosphatase activity of SaOS-2 cells. J. Med. Food, 2003; 6: 79-86
  Google Scholar
• 24. Kong K.W., Khoo H.E., Prasad K.N., Ismail A., Tan C.P., Rajab N.F.:Revealing the power of the natural red pigment lycopene. Molecules,2010; 15: 959-987
  Google Scholar
• 25. Kulbacka J., Saczko J., Chwiłkowska A.: Stres oksydacyjny w procesachuszkodzenia komórek. Pol. Merkur. Lekarski, 2009; 27: 44-47
  Google Scholar
• 26. Kumar N.B., Besterman-Dahan K., Kang L., Pow-Sang J., Xu P.,Allen K., Riccardi D., Krischer J.P.: Results of a randomized clinicaltrial of the action of several doses of lycopene in localized prostatecancer: administration prior to radical prostatectomy. Clin. Med.Urol., 2008; 1: 1-14
  Google Scholar
• 27. Liang H., Yu F., Tong Z., Zeng W.: Lycopene effects on serummineral elements and bone strength in rats. Molecules, 2012; 17:7093-7102
  Google Scholar
• 28. Mackinnon E.S., El-Sohemy A., Rao A.V., Rao L.G.: Paraoxonase 1 polymorphisms 172T→A and 584A→G modify the association betweenserum concentrations of the antioxidant lycopene and boneturnover markers and oxidative stress parameters in women 25-70years of age. J. Nutrigenet. Nutrigenomics, 2010; 3: 1-8
  Google Scholar
• 29. Mackinnon E.S., Rao A.V., Josse R.G., Rao L.G.: Supplementationwith the antioxidant lycopene significantly decreases oxidativestress parameters and the bone resorption marker N-telopeptide oftype I collagen in postmenopausal women. Osteoporos. Int., 2011;22: 1091-1101
  Google Scholar
• 30. Mackinnon E.S., Rao A.V., Rao L.G.: Dietary restriction of lycopenefor a period of one month resulted in significantly increasedbiomarkers of oxidative stress and bone resorption in postmenopausalwomen. J. Nutr. Health Aging, 2011; 15: 133-138
  Google Scholar
• 31. Maggio D., Polidori M.C., Barabani M., Tufi A., Ruggiero C., CecchettiR., Aisa M.C., Stahl W., Cherubini A.: Low levels of carotenoidsand retinol in involutional osteoporosis. Bone, 2006; 38: 244-248
  Google Scholar
• 32. Maiani G., Castón M.J., Catasta G., Toti E., Cambrodón I.G., BystedA., Granado-Lorencio F., Olmedilla-Alonso B., Knuthsen P., ValotiM., Böhm V., Mayer-Miebach E., Behsnilian D., Schlemmer U.: Carotenoids:actual knowledge on food sources, intakes, stability andbioavailability and their protective role in humans. Mol. Nutr. FoodRes., 2009; 53 (Suppl. 2): S194-S218
  Google Scholar
• 33. Manolagas S.C.: From estrogen-centric to aging and oxidativestress: a revised perspective of the pathogenesis of osteoporosis.Endocr. Rev., 2010; 31: 266-300
  Google Scholar
• 34. Manolagas S.C., Parfitt A.M.: What old means to bone. TrendsEndocrinol. Metab., 2010; 21: 369-374
  Google Scholar
• 35. Maoka T.: Carotenoids in marine animals. Mar. Drugs, 2011; 9:278-293
  Google Scholar
• 36. Niedźwiecki T, Kuryszko J.J.: Biologia kości. Wydawnictwo NaukowePWN, Warszawa 2007
  Google Scholar
• 37. Nieves J.W.: Skeletal effects of nutrients and nutraceuticals,beyond calcium and vitamin D. Osteoporos. Int., 2013; 24: 771-786
  Google Scholar
• 38. Palozza P., Catalano A., Simone R., Cittadini A.: Lycopene asa guardian of redox signalling. Acta Biochim. Pol., 2012; 59: 21-25
  Google Scholar
• 39. Palozza P., Parrone N., Catalano A., Simone R.: Tomato lycopeneand inflammatory cascade: basic interactions and clinical implications.Curr. Med. Chem., 2010; 17: 2547-2563
  Google Scholar
• 40. Pan M.H., Lai C.S., Tsai M.L., Wu J.C., Ho C.T.: Molecular mechanismsfor anti-aging by natural dietary compounds. Mol. Nutr. FoodRes., 2012; 56: 88-115
  Google Scholar
• 41. Park C.K., Ishimi Y., Ohmura M., Yamaguchi M., Ikegami S.: VitaminA and carotenoids stimulate differentiation of mouse osteoblasticcells. J. Nutr. Sci. Vitaminol., 1997; 43: 281-296
  Google Scholar
• 42. Raisz L.G.: Pathogenesis of osteoporosis: concepts, conflicts, andprospects. J. Clin. Invest., 2005; 115: 3318-3325
  Google Scholar
• 43. Rao A.V., Rao L.G.: Carotenoids and human health. Pharmacol.Res., 2007; 55: 207-216
  Google Scholar
• 44. Rao L.G., Krishnadev N., Banasikowska K., Rao A.V.: LycopeneI – effect on osteoclasts: lycopene inhibits basal and parathyroidhormone-stimulated osteoclast formation and mineral resorptionmediated by reactive oxygen species in rat bone marrow cultures.J. Med. Food, 2003; 6: 69-78
  Google Scholar
• 45. Rao L.G., Mackinnon E.S., Josse R.G., Murray T.M., Strauss A., RaoA.V.: Lycopene consumption decreases oxidative stress and boneresorption markers in postmenopausal women. Osteoporos. Int.,2007; 18: 109-115
  Google Scholar
• 46. Rao L.G., Rao A.V.: Oxidative stress and antioxidants in the riskof osteoporosis – role of the antioxidants lycopene and polyphenols.W: Topics in Osteoporosis, red.: Valdés-Flores M., InTech, 2013
  Google Scholar
• 47. Riccioni G., Mancini B., Di Ilio E., Bucciarelli T., D’Orazio N.: Protectiveeffect of lycopene in cardiovascular disease. Eur. Rev. Med.Pharmacol. Sci., 2008; 12: 183-190
  Google Scholar
• 48. Ried K., Fakler P.: Protective effect of lycopene on serum cholesteroland blood pressure: Meta-analyses of intervention trials.Maturitas, 2011; 68: 299-310
  Google Scholar
• 49. Rivas A., Romero A., Mariscal-Arcas M., Monteagudo C., LópezG., Lorenzo M.L., Ocaña-Peinado F.M., Olea-Serrano F.: Associationbetween dietary antioxidant quality score (DAQs) and bone mineraldensity in Spanish women. Nutr. Hosp., 2012; 27: 1886-1893
  Google Scholar
• 50. Rochefort G.Y., Pallu S., Benhamou C.L.: Osteocyte: the unrecognizedside of bone tissue. Osteoporos. Int., 2010; 21: 1457-1469
  Google Scholar
• 51. Ross A.B., Vuong le T., Ruckle J., Synal H.A., Schulze-König T.,Wertz K., Rümbeli R., Liberman R.G., Skipper P.L., Tannenbaum S.R.,Bourgeois A., Guy P.A., Enslen M., Nielsen I.L., Kochhar S. i wsp.:Lycopene bioavailability and metabolism in humans: an acceleratormass spectrometry study. Am. J. Clin. Nutr., 2011; 93: 1263-1273
  Google Scholar
• 52. Sacco S.M., Horcajada M.N., Offord E.: Phytonutrients for bonehealth during ageing. Br. J. Clin. Pharmacol., 2013; 75: 697-707
  Google Scholar
• 53. Sahin K., Sahin N., Kucuk O.: Lycopene and chemotherapy toxicity.Nutr. Cancer, 2010; 62: 988-995
  Google Scholar
• 54. Sahni S., Hannan M., Blumberg J., Cupples L.A., Kiel D.P., TuckerK.L.: Inverse association of carotenoid intakes with 4-y change inbone mineral density in elderly men and women: the FraminghamOsteoporosis Study. Am. J. Clin. Nutr., 2009; 89: 416-424
  Google Scholar
• 55. Sahni S., Hannan M.T., Blumberg J., Cupples L.A., Kiel D.P., TuckerK.L.: Protective effect of total carotenoid and lycopene intake on therisk of hip fracture: a 17-year follow-up from the Framingham OsteoporosisStudy. J. Bone Miner. Res., 2009; 24: 1086-1094
  Google Scholar
• 56. Sapian-Raczkowska B., Rabczyński M., Adamiec R.: Paraoksonaza– ważny enzym przemian lipidowych i potencjalny sprzymierzeniecw leczeniu przeciwmiażdżycowym. Pol. Merkur. Lekarski, 2010; 29:325-327
  Google Scholar
• 57. Sarkar P.D., Sahu A., Gupta T.: Assessment of alkaline phosphatase(bone specific) activity after lycopene supplementation in relationto antioxidant status in osteoporotic patients. Int. J. Clin. CasesInvest., 2012; 4: 90-100
  Google Scholar
• 58. Shen C.L., von Bergen V., Chyu M.C., Jenkins M.R., Mo H., ChenC.H., Kwun I.S.: Fruits and dietary phytochemicals in bone protection.Nutr. Res., 2012; 32: 897-910
  Google Scholar
• 59. Sporn M.B., Liby K.T.: Is lycopene an effective agent for preventingprostate cancer? Cancer Prev. Res., 2013; 6: 384-386
  Google Scholar
• 60. Sugiura M., Nakamura M., Ogawa K., Ikoma Y., Yano M.: Highserum carotenoids associated with lower risk for bone loss and osteoporosisin post-menopausal Japanese female subjects: prospectivecohort study. PLoS One, 2012; 7: e52643
  Google Scholar
• 61. Veprik A., Khanin M., Linnewiel-Hermoni K., Danilenko M., LevyJ., Sharoni Y.: Polyphenols, isothiocyanates, and carotenoid derivativesenhance estrogenic activity in bone cells but inhibit it in breastcancer cells. Am. J. Physiol. Endocrinol. Metab., 2012; 303: E815-E824
  Google Scholar
• 62. Wang X.D.: Lycopene metabolism and its biological significance.Am. J. Clin. Nutr., 2012; 96: 1214S-1222S
  Google Scholar
• 63. Wattanapenpaiboon N., Lukito W., Wahlqvist M.L., Strauss B.J.:Dietary carotenoid intake as a predictor of bone mineral density.Asia Pac. J. Clin. Nutr., 2003; 12: 467-473
  Google Scholar
• 64. Wolf R.L., Cauley J.A., Pettinger M., Jackson R., Lacroix A., LeboffM.S., Lewis C.E., Nevitt M.C., Simon J.A., Stone K.L., Wactawski-WendeJ.: Lack of a relation between vitamin and mineral antioxidants andbone mineral density: results from the Women’s Health Initiative.Am. J. Clin. Nutr., 2005; 82: 581-588
  Google Scholar
• 65. Yamaguchi M., Uchiyama S.: Effect of carotenoid on calciumcontent and alkaline phosphatase activity in rat femoral tissues invitro: the unique anabolic effect of β-cryptoxanthin. Biol. Pharm.Bull., 2003; 26: 1188-1191
  Google Scholar
• 66. Yang X.Z., Ji C.J., Wang D.C., Chen X.L.: Antiosteoporotic activityof lycopene in mature ovariectomized rats. Chinese J. Tissue Eng.Res., 2012; 16: 2750-2756
  Google Scholar
• 67. Yang Z., Zhang Z., Penniston K.L., Binkley N., Tanumihardjo S.A.:Serum carotenoid concentrations in postmenopausal women fromthe United States with and without osteoporosis. Int. J. Vitam. Nutr.Res., 2008; 78: 105-111
  Google Scholar
• 68. Zhang H., Chen X., Wang D., Zheng X., Chen Z.: The effect of lycopeneon osteoblasts which have incurred oxidative stress. ChineseJ. Osteoporosis, 2007; 13: 86-90 (streszczenie angielskie)
  Google Scholar

Full text